# Autonomix Medical Inc. (AMIX)

Source: https://www.quantisnow.com/company/AMIX
Generated: 2026-10-29T01:19:27.685Z

- Ticker: AMIX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2024
- SEC CIK: 0001617867

## Latest AMIX news and filings

- 2026-10-13 18:05 UTC [SEC Form 3] [SEC Form 3 filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-autonomix-medical-inc-6744845)
- 2026-10-02 12:05 UTC [Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation](https://www.quantisnow.com/insight/autonomix-medical-strengthens-patent-protection-for-platform-technology-enabling-precision-6733512)
- 2026-09-30 12:30 UTC [Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance](https://www.quantisnow.com/insight/autonomix-reports-positive-fda-feedback-supporting-510k-pathway-to-us-6730075)
- 2026-09-24 12:30 UTC [Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform](https://www.quantisnow.com/insight/autonomix-medical-expands-global-intellectual-property-footprint-with-european-patent-6724926)
- 2026-09-21 12:13 UTC [SEC Form 4] [CFO Smith Trent N. was granted 15,000 shares, increasing direct ownership by 12,605% to 15,119 units (SEC Form 4)](https://www.quantisnow.com/insight/cfo-smith-trent-n-was-granted-15000-shares-increasing-direct-6721282)
- 2026-09-16 21:02 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-autonomix-medical-inc-6717892)
- 2026-09-16 12:35 UTC [SEC Form 8-K] [Autonomix Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/autonomix-medical-inc-filed-sec-form-8-k-leadership-update-financial-6717057)
- 2026-09-16 12:30 UTC [Leadership Update] [Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors](https://www.quantisnow.com/insight/autonomix-medical-appoints-former-medtronic-chief-regulatory-counsel-sandra-cohen-6717025)
- 2026-09-16 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-autonomix-medical-inc-6716792)
- 2026-09-14 21:10 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-autonomix-medical-inc-6714863)
- 2026-09-14 21:02 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-autonomix-medical-inc-6714819)
- 2026-09-11 21:00 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-autonomix-medical-inc-6713248)
- 2026-09-08 20:23 UTC [SEC Form 4] [Director Klemp Walter V was granted 13,000 shares, increasing direct ownership by 183% to 20,118 units (SEC Form 4)](https://www.quantisnow.com/insight/director-klemp-walter-v-was-granted-13000-shares-increasing-direct-6708428)
- 2026-09-08 20:21 UTC [SEC Form 4] [Director Bisson Lori was granted 13,000 shares, increasing direct ownership by 10,924% to 13,119 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bisson-lori-was-granted-13000-shares-increasing-direct-ownership-6708415)
- 2026-09-08 20:19 UTC [SEC Form 4] [CEO and President Hauser Bradley was granted 27,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/ceo-and-president-hauser-bradley-was-granted-27000-shares-sec-6708405)
- 2026-09-04 21:10 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-autonomix-medical-inc-6706970)
- 2026-09-04 21:01 UTC [SEC Form S-3] [SEC Form S-3 filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-autonomix-medical-inc-6706916)
- 2026-09-01 12:30 UTC [Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026](https://www.quantisnow.com/insight/autonomix-medical-announces-acceptance-of-two-abstracts-for-poster-presentation-6700706)
- 2026-08-26 21:02 UTC [SEC Form 8-K] [Autonomix Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/autonomix-medical-inc-filed-sec-form-8-k-entry-into-a-6695899)
- 2026-08-26 12:30 UTC [Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery](https://www.quantisnow.com/insight/autonomix-medical-expands-intellectual-property-portfolio-with-new-us-patent-6695099)
- 2026-08-25 01:06 UTC [Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules](https://www.quantisnow.com/insight/autonomix-medical-enters-into-49-million-warrant-inducement-priced-at-6693342)
- 2026-08-12 23:40 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-autonomix-medical-inc-6678963)
- 2026-08-12 12:15 UTC [Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission](https://www.quantisnow.com/insight/autonomix-medical-completes-good-laboratory-practice-glp-preclinical-study-marking-6677139)
- 2026-08-10 12:20 UTC [Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award](https://www.quantisnow.com/insight/autonomix-medical-congratulates-co-founder-chief-medical-officer-dr-robert-schwartz-6672896)
- 2026-08-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-autonomix-medical-inc-6663626)
- 2026-08-04 12:15 UTC [Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy](https://www.quantisnow.com/insight/autonomix-medical-expands-precision-neuromodulation-platform-with-broad-new-us-6661243)
- 2026-07-31 21:00 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-autonomix-medical-inc-6658158)
- 2026-07-28 21:01 UTC [SEC Form S-3] [SEC Form S-3 filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-autonomix-medical-inc-6652057)
- 2026-07-28 15:36 UTC [SEC Form 8-K] [Autonomix Medical Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/autonomix-medical-inc-filed-sec-form-8-k-other-events-6651093)
- 2026-07-24 12:47 UTC [Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study](https://www.quantisnow.com/insight/autonomix-medical-demonstrates-renal-nerve-sensing-and-neural-activity-change-6648013)
- 2026-07-23 11:30 UTC [Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform](https://www.quantisnow.com/insight/autonomix-medical-secures-new-us-patent-strengthening-next-generation-precision-neuromodulation-6646184)
- 2026-07-15 21:02 UTC [SEC Form 8-K] [Autonomix Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/autonomix-medical-inc-filed-sec-form-8-k-entry-into-a-6638571)
- 2026-07-15 12:00 UTC [Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform](https://www.quantisnow.com/insight/autonomix-medical-granted-us-patent-for-overactive-bladder-diagnosis-and-6637625)
- 2026-07-14 01:30 UTC [Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/autonomix-medical-enters-into-26-million-warrant-inducement-priced-at-the-market-6635826)
- 2026-07-13 11:30 UTC [Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant](https://www.quantisnow.com/insight/autonomix-medical-strengthens-global-intellectual-property-position-with-new-neural-6634784)
- 2026-07-10 12:32 UTC [SEC Form 8-K] [Autonomix Medical Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/autonomix-medical-inc-filed-sec-form-8-k-other-events-6633684)
- 2026-06-24 11:00 UTC [SEC Form 8-K] [Autonomix Medical Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/autonomix-medical-inc-filed-sec-form-8-k-material-modification-to-6613503)
- 2026-06-22 12:00 UTC [Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change](https://www.quantisnow.com/insight/autonomix-medical-announces-standalone-neural-sensing-program-with-evidence-of-6610027)
- 2026-06-18 20:30 UTC [Autonomix Announces Reverse Stock Split](https://www.quantisnow.com/insight/autonomix-announces-reverse-stock-split-6608970)
- 2026-06-15 21:28 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Autonomix Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-autonomix-medical-inc-6603286)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AMIX
- RSS and alerts for AMIX: https://www.quantisnow.com/docs/rss-feeds.md